Global Anastomosis Devices Market: Key Developments
In January 2022, Seger Surgical Solutions commenced the development of next-gen laparoscopic bowel closure device for intracorporeal anastomosis (IA). The new device, named LAP IA 60, is capable of aligning, closing, and stapling a common opening for intracorporeal anastomosis quickly, securely, and without the need for suturing.
In March 2021, Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the Food and Drug Administration (FDA) for VIOLA. This is a new device for clampless proximal anastomosis in Coronary Artery Bypass Graft (CABG).
In September 2020, GI Windows Medical Corporation announced that the U.S. FDA has granted Breakthrough Device Designation for the self-forming magnetic compression anastomosis device indicated for small bowel end to end anastomosis for ileostomy reversal or tissue resection.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients